on 29 Feb 2024
Last Applicant/ Owned by
Cure EB
10 Huntingdon Street
LONDON, , N1 1BU
Serial Number
UK00004019997 filed on 29th Feb 2024
Correspondent Information
Fielding IP Limited
37 Chatterton Road
London,
London,
N4 2EA
Printed matter; promotional material; brochures; leaflets and posters; printed publications; medical journals; health care newsletters; patient education brochures; printed research reports; all of the aforesaid relating to Epidermolysis Bullosa.
Fundraising activities; charitable fund-raising services; fund raising using crowdfunding; grant giving; accepting monetary charitable contributions to fund medical research; financial grant services; providing financial funds to organisations and individuals for the purpose of research, treatment and/or prevention of Epidermolysis Bullosa; charitable investments; financial sponsorship; information, advisory and consultancy services relating to all the aforesaid.
In relation to Epidermolysis Bullosa: education; provision of training; provision of courses and conferences; provision of on-line electronic publications and on-line materials; educational services, namely, conducting programs, seminars, lectures and workshops in the fields of medicine and healthcare relating to Epidermolysis Bullosa; developing and disseminating educational materials relating to Epidermolysis Bullosa; developing and disseminating educational materials and programs to physicians and patients regarding Epidermolysis Bullosa, and distribution of printed materials therewith; information, advisory and consultancy services relating to all the aforesaid. .
In relation to Epidermolysis Bullosa: clinical research; conducting clinical research projects; clinical research; biological research, clinical research and medical research; scientific research and analysis; preparation of reports relating to scientific research; scientific research and development; scientific research; scientific, analysis, research design and medical research services relating to Epidermolysis Bullosa; research relating to the needs and views of people affected by Epidermolysis Bullosa; research services in relation to the causes, symptoms, diagnosis, treatment and prevention of Epidermolysis Bullosa; medical research services; information, advisory and consultancy services relating to all the aforesaid. .
In relation to Epidermolysis Bullosa: consulting services, namely, consulting on the treatment of Epidermolysis Bullosa, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment and patient care management; computer information services, namely, providing information on Epidermolysis Bullosa and disease management via a global computer network; medical, healthcare, and wellness services; providing consulting services in the fields of medicine, healthcare, and wellness; providing online news and information in the fields of medicine, healthcare, and wellness via websites; providing medical information; medical information; providing information to patients in the field of administering medications; medical care and analysis services relating to patient treatment; provision of medical information; providing health information; providing on-line information relating to Epidermolysis Bullosa; healthcare information services; health advice and information services; information, advisory and consultancy services relating to all the aforesaid. .
UK00004019997
Word
Individual